Free Gap Assessment

Manufacturing

Streamlining Pharmaceutical Manufacturing

Where the time actually goes on a production floor, and how tighter quality control and documentation cut cost, recalls and review cycles.

Technician in gown, mask and gloves pipetting in a pharmaceutical production laboratory

The floor is rarely the bottleneck

Ask a plant manager where a batch loses time and the answer is usually a machine. Measure it and the answer is usually paper. Granulation runs to schedule. Compression runs to schedule. Then the batch sits, waiting on a review that takes four days because three entries were made in the wrong order and the deviation has to be investigated before release.

Equipment throughput is visible, so it gets optimised. Review cycle time is invisible, so it does not. On most sites we assess, the gap between physical processing time and actual release time is the single largest recoverable cost in the operation.

Three places the time goes

  • Documentation rework. Batch records designed for a different line, so operators improvise entries and QA queries them.
  • Deviation handling. No triage, so a minor entry correction consumes the same investigation effort as a genuine quality event.
  • Changeover and cleaning. Validated cleaning limits set conservatively years ago and never revisited against actual product data.

Tighter quality control is faster, not slower

There is a persistent belief that more quality control means more delay. In practice the opposite holds. Controls applied at the point of operation catch a problem while it costs one batch. Controls applied at review catch it after the campaign, when the decision is a recall.

In-process checks with clear accept and reject limits, recorded once and reviewed by exception, shorten the review queue rather than lengthening it. The paperwork is not the burden. Ambiguous paperwork is.

What changes after a documentation rebuild

Rebuilding a batch record set around the line as it actually runs typically removes a large share of routine deviations, because most of them were never quality events, only recording mismatches. Review moves from reading everything to reading exceptions. Release time compresses, and the quality signal gets stronger, not weaker, because genuine events stop being buried in noise.

Where to start

Take one product family. Time it end to end, from dispensing to release, and separate processing time from waiting time. The result usually settles the argument about where to invest, and it costs nothing but attention.

Leave a Reply

Your email address will not be published. Required fields are marked *